Thalidomide, the notorious drug which caused horrendous birth defects in the 1950s and 1960s, is close to making a comeback as an anticancer drug. Drug firm Celgene of Warren, New Jersey, has applied to European drug authorities for permission to sell thalidomide to treat multiple myeloma, a fatal cancer of the bone marrow. In clinical trials the drug performed well against the disease. It will take Europe seven months or more to reach a verdict on the drug, which will not be prescribed to pregnant women or those considering having children.
To continue reading, today with our introductory offers
Advertisement
More from 51¶¯Âþ
Explore the latest news, articles and features
Popular articles
Trending 51¶¯Âþ articles
1
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
2
Photos reveal unexpected details from the world's first atomic test
3
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
4
How I used psychology to come back from the worst year of my life
5
The distant world that is our best hope of finding alien life
6
The ‘doomsday’ glacier’s giant ice shelf is about to break away
7
Epic dreaming is leaving people exhausted and distressed
8
The 3 things you need to know about protein, according to an expert
9
Putting CO2 into rocks and getting hydrogen out is climate double win
10
Women’s better memories may delay Alzheimer’s diagnosis by years
